Wings Therapeutics
PrivateCompany Overview
Wings Therapeutics is a biotechnology company that develops transformational therapies for Dystrophic Epidermolysis Bullosa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
dystrophic epidermolysis bullosaDEBRNA therapyantisense oligonucleotideASOexon skippingrare disease drugorphan drugtopical therapybiopharmaceuticalprecision medicineclinical stage biotechventure philanthropydrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wings Therapeutics Comparables
Compare Wings Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phoenicis Therapeutics | 86% | |
| Nova Anchora | 85% | |
| Castle Creek Biosciences | 83% | |
Wings Therapeutics Funding Rounds
Historical fundraising activity
Wings Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Wings Therapeutics's valuation, stock price, and market status.